Company Filing History:
1 out of 54 
1 out of 15,579 
Years Active: 2009
Title: Johanna A Joyce: Innovator in Targeted Therapeutics
Introduction
Johanna A Joyce is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of targeted therapeutics, particularly in the development of molecules that selectively target the vasculature of premalignant or malignant lesions of the pancreas and other organs. Her innovative work has the potential to enhance treatment options for pancreatic cancer and other related conditions.
Latest Patents
Johanna A Joyce holds a patent for her invention titled "Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs." This invention provides a conjugate that includes a therapeutic moiety linked to a peptide or peptidomimetic that selectively homes to the vasculature of the premalignant pancreas. The peptide or peptidomimetic contains at least 5 contiguous amino acids from specific amino acid sequences, allowing for targeted delivery to pancreatic tumor cells and their vasculature.
Career Highlights
Throughout her career, Johanna has worked with esteemed institutions such as the Burnham Institute for Medical Research and the University of California. Her research has focused on the intersection of molecular biology and therapeutic development, leading to advancements in cancer treatment.
Collaborations
Johanna has collaborated with notable scientists, including Douglas Hanahan and Erkki I Ruoslahti. These partnerships have fostered innovative research and contributed to the advancement of targeted therapies in oncology.
Conclusion
Johanna A Joyce is a trailblazer in the field of targeted therapeutics, with a patent that showcases her innovative approach to treating pancreatic lesions. Her work continues to inspire advancements in cancer research and therapy.